FDA clears Boston Scientific Bolt IVL system
March 31, 2025
Boston Scientific (NYSE: BSX) has received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA’s 510(k) database.
Boston Scientific (NYSE: BSX) has received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA’s 510(k) database.
WASHINGTON, March 31, 2025 /PRNewswire/ — MedStar Georgetown University Hospital is the first hospital in the Washington, D.C. region to offer bedside intestinal ultrasound (IUS) to monitor inflammation in IBD patients. To assess chronic inflammatory diseases of the intestines, like Crohn’s disease and ulcerative colitis, patients are traditionally monitored with blood tests, stool studies, MRI or CT scans, and colonoscopies. Those kinds of tests can require bowel preparation, sedation, anesthesia, and radiation.
PARIS, March 31, 2025 /PRNewswire/ — AZmed, one of the leading AI companies in medical imaging, today announced that it has received two new U.S. Food and Drug Administration (FDA) clearances for its AI tool AZchest. The clearances include applications intended to assist radiologists in the interpretation and detection of chest X-rays for lung nodules and triage capabilities for pneumothorax and pleural effusion.
With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems already on the market.
Device goes beyond the buzz to create a sophisticated variety of haptic sensations
Social media has far more intrusive information than genomic data, genetic justice expert says
SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval.
Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery.
A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with company partner DOC Medikus GmbH, has developed an innovative bioanalytical test system for radiopharmaceutical drug candidates for cancer diagnosis and therapy.
SCOTTSDALE, Ariz., March 20, 2025 /PRNewswire/ — Anuncia Medical, Inc. (“Anuncia”), a pioneering company in CSF management and neurocritical care, has received Breakthrough Device Designation from the FDA for its ReFlow® EVD, an innovative solution for external ventricular drains (EVDs) used to manage brain swelling and elevated intracranial pressure.